US Broker Ratings

NewAmsterdam Pharma (NAMS) Stock Report: Exploring a 52% Upside with Innovative Biotech Solutions

NewAmsterdam Pharma Company N.V. (NAMS) is drawing significant attention from investors with its promising pipeline in the biotechnology sector. With a market capitalization of $3.05 billion, this Netherlands-based firm is..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a Potential 56.66% Upside

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent provider of outpatient mental health services, has caught the attention of investors with its potential for significant upside. As a company deeply..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 23% Upside Potential Amid Biotech Innovations

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is capturing the attention of investors with a compelling growth narrative in the healthcare sector. As a leading player in the biotechnology industry, Kymera is..

Apellis Pharmaceuticals (APLS) Stock Report: Analyst Ratings Signal 61% Upside Potential in Biotechnology

For investors with an eye on the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a compelling opportunity. This U.S.-based biopharmaceutical company, with a market cap of approximately $2.97 billion,..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A Biotech Powerhouse with a 44.73% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing investor attention with its robust pipeline and an impressive potential upside of 44.73%. Specializing in the development of RNA interference medicines for intractable..

Viking Therapeutics (VKTX) Stock Analysis: Exploring a Potential 251.60% Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out as a compelling opportunity in the biotechnology sector, part of the larger healthcare ecosystem. As a clinical-stage biopharmaceutical company based in San Diego,..

Alvotech (ALVO) Stock Analysis: Exploring a 118% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) is attracting significant attention from investors, thanks to its ambitious biosimilar product pipeline and the potential for a substantial stock price appreciation. With a market capitalization of..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 17.15% Potential Upside with Strong Buy Ratings

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing investor attention with its innovative approach to cancer diagnostics. Headquartered..

IDEAYA Biosciences, Inc. (IDYA) Investor Outlook: Analyzing an 81.55% Potential Upside in Biotechnology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine in the biotechnology sector, offering a compelling investment opportunity with a potential upside of 81.55%. Specializing in targeted..

CG Oncology, Inc. (CGON) Stock Analysis: A 70.82% Upside Potential in the Biotech Sector

Investors looking to capitalize on the healthcare sector’s dynamic potential should turn their attention to CG Oncology, Inc. (NASDAQ: CGON), a promising player in the biotechnology industry. With a market..

Bausch Health Companies Inc. (BHC) Stock Analysis: Evaluating Growth Potential with an Enticing Upside

Bausch Health Companies Inc. (NYSE: BHC), a major player in the healthcare sector, operates as a diversified specialty pharmaceutical and medical device company. With its headquarters in Laval, Canada, Bausch..

Certara, Inc. (CERT) Stock Analysis: 20.92% Potential Upside in Health Information Services

Certara, Inc. (CERT), a key player in the healthcare sector, specifically within health information services, has caught the attention of individual investors seeking opportunities in technologically-driven biosimulation solutions. With a..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 64.58% Potential Upside Amidst Solid Dividend Yield

Perrigo Company plc (NASDAQ: PRGO), a stalwart in the healthcare sector, is turning heads with its notable potential upside of 64.58%, making it a compelling consideration for investors seeking growth..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Promising 23.59% Potential Upside Attracts Investor Interest

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the healthcare sector, stands out in the biotechnology industry with its focus on central nervous system (CNS) disorders and rare diseases...

Galapagos NV (GLPG) Stock Analysis: Navigating Uncharted Biotech Waters Amidst a -23% Potential Downside

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is at a crossroads as it navigates the challenging waters of the healthcare sector. With a current market capitalization of $2.24 billion,..

Haemonetics Corporation (HAE) Stock Analysis: Uncovering a 53.65% Potential Upside Amid Healthcare Innovation

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, specializes in medical devices and technologies crucial for modern hospital operations. With a market capitalization of $2.47 billion, Haemonetics..

GeneDx Holdings Corp. (WGS) Stock Analysis: Decoding Growth Potential in the Genomics Sector

GeneDx Holdings Corp. (WGS), a pivotal player in the healthcare sector, stands at the forefront of the diagnostics and research industry. With a market capitalization of $3.73 billion, the company’s..

Ascentage Pharma Group Internat (AAPG): Analyst Ratings Indicate a Promising Future in Biotechnology

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, is attracting attention with its innovative approach to treating some of the most challenging health conditions, including cancer..

Concentra Group Holdings Parent (CON) Stock Analysis: A Robust 34.76% Upside Potential in the Healthcare Sector

Concentra Group Holdings Parent, Inc. (CON), a formidable player in the healthcare sector, has emerged as a compelling prospect for investors. Specializing in occupational health services, Concentra not only addresses..

Envista Holdings Corporation (NVST) Stock Analysis: A Healthcare Innovator with a Modest Upside

Envista Holdings Corporation (NYSE: NVST), a notable player in the healthcare sector, specializes in the development and distribution of dental products, offering a diverse range of solutions across its Specialty..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds